NCT06821594View on ClinicalTrials.gov

Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

August 30, 2025

Study Completion Date

September 30, 2025

Conditions
Cutaneous Warts
Interventions
DRUG

Furosemide

Furosemide 20mg/2ml and digoxin 0.5mg/2ml given 0.2 ml into the wart base once weekly for 5 weeks

Trial Locations (1)

75500

Jinnah Postgraduate Medical Centre, Karachi

All Listed Sponsors
lead

Jinnah Postgraduate Medical Centre

OTHER_GOV